| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Beyond audiofacial morbidity after vestibular schwannoma surgery.
|
J Neurosurg
|
2009
|
1.59
|
|
2
|
Intratumoral hemorrhage and fibrosis in vestibular schwannoma: a possible mechanism for hearing loss.
|
J Neurosurg
|
2010
|
1.55
|
|
3
|
Extent of resection and the long-term durability of vestibular schwannoma surgery.
|
J Neurosurg
|
2011
|
1.53
|
|
4
|
Gliomas: advances in molecular analysis and characterization.
|
Surg Neurol
|
2005
|
1.46
|
|
5
|
The molecular genetics and tumor pathogenesis of meningiomas and the future directions of meningioma treatments.
|
Neurosurg Focus
|
2011
|
1.33
|
|
6
|
Primary gliosarcoma: key clinical and pathologic distinctions from glioblastoma with implications as a unique oncologic entity.
|
J Neurooncol
|
2009
|
1.25
|
|
7
|
Temozolomide and other potential agents for the treatment of glioblastoma multiforme.
|
Neurosurg Clin N Am
|
2012
|
1.13
|
|
8
|
A systematic review of intracranial chondrosarcoma and survival.
|
J Clin Neurosci
|
2009
|
1.13
|
|
9
|
Leptomeningeal spinal metastases from glioblastoma multiforme: treatment and management of an uncommon manifestation of disease.
|
J Neurosurg Spine
|
2012
|
1.11
|
|
10
|
Monitoring of regulatory T cell frequencies and expression of CTLA-4 on T cells, before and after DC vaccination, can predict survival in GBM patients.
|
PLoS One
|
2012
|
1.07
|
|
11
|
Cranial chondrosarcoma and recurrence.
|
Skull Base
|
2010
|
1.06
|
|
12
|
Clinical characteristics and outcomes for a modern series of primary gliosarcoma patients.
|
Cancer
|
2010
|
1.02
|
|
13
|
Endocrinologic, neurologic, and visual morbidity after treatment for craniopharyngioma.
|
J Neurooncol
|
2010
|
0.97
|
|
14
|
The natural history of untreated sporadic vestibular schwannomas: a comprehensive review of hearing outcomes.
|
J Neurosurg
|
2010
|
0.96
|
|
15
|
Secondary gliosarcoma after diagnosis of glioblastoma: clinical experience with 30 consecutive patients.
|
J Neurosurg
|
2010
|
0.95
|
|
16
|
CD133 as a marker for regulation and potential for targeted therapies in glioblastoma multiforme.
|
Neurosurg Clin N Am
|
2012
|
0.94
|
|
17
|
Fluctuating response of a cystic vestibular schwannoma to radiosurgery: case report.
|
Neurosurgery
|
2008
|
0.94
|
|
18
|
Immunological considerations of modern animal models of malignant primary brain tumors.
|
J Transl Med
|
2009
|
0.93
|
|
19
|
Interferon-gamma in brain tumor immunotherapy.
|
Neurosurg Clin N Am
|
2010
|
0.93
|
|
20
|
Clinical characteristics and diagnostic imaging of epidermoid tumors.
|
J Clin Neurosci
|
2011
|
0.92
|
|
21
|
miRNA contents of cerebrospinal fluid extracellular vesicles in glioblastoma patients.
|
J Neurooncol
|
2015
|
0.90
|
|
22
|
Gamma interferon-mediated superinduction of B7-H1 in PTEN-deficient glioblastoma: a paradoxical mechanism of immune evasion.
|
Neuroreport
|
2009
|
0.90
|
|
23
|
The molecular biology and novel treatments of vestibular schwannomas.
|
J Neurosurg
|
2011
|
0.90
|
|
24
|
A comprehensive analysis of intracranial chordoma and survival: a systematic review.
|
Br J Neurosurg
|
2011
|
0.90
|
|
25
|
Preservation of facial nerve function after resection of vestibular schwannoma.
|
Br J Neurosurg
|
2010
|
0.89
|
|
26
|
Microglia and central nervous system immunity.
|
Neurosurg Clin N Am
|
2010
|
0.88
|
|
27
|
Complications associated with the treatment for spinal ependymomas.
|
Neurosurg Focus
|
2011
|
0.87
|
|
28
|
Secondary gliosarcoma: a review of clinical features and pathological diagnosis.
|
J Neurosurg
|
2010
|
0.87
|
|
29
|
Characteristics and management of superior semicircular canal dehiscence.
|
J Neurol Surg B Skull Base
|
2012
|
0.86
|
|
30
|
Factors associated with preservation of facial nerve function after surgical resection of vestibular schwannoma.
|
J Neurooncol
|
2010
|
0.86
|
|
31
|
Prognostic factors for post-operative seizure outcomes after cavernous malformation treatment.
|
J Clin Neurosci
|
2011
|
0.86
|
|
32
|
Survival outcomes for radiotherapy treatment of epidermoid tumors with malignant transformation.
|
J Clin Neurosci
|
2011
|
0.85
|
|
33
|
Heat shock protein-peptide complex in the treatment of glioblastoma.
|
Expert Rev Vaccines
|
2011
|
0.83
|
|
34
|
Relationship between valve opening pressure, body position, and intracranial pressure in normal pressure hydrocephalus: paradigm for selection of programmable valve pressure setting.
|
Neurosurgery
|
2004
|
0.83
|
|
35
|
Hearing preservation rates after microsurgical resection of vestibular schwannoma.
|
J Clin Neurosci
|
2010
|
0.83
|
|
36
|
Intraoperative neuromonitoring techniques in the surgical management of acoustic neuromas.
|
Neurosurg Focus
|
2012
|
0.83
|
|
37
|
Implications for immunotherapy of tumor-mediated T-cell apoptosis associated with loss of the tumor suppressor PTEN in glioblastoma.
|
J Clin Neurosci
|
2010
|
0.81
|
|
38
|
Non-audiofacial morbidity after Gamma Knife surgery for vestibular schwannoma.
|
Neurosurg Focus
|
2009
|
0.81
|
|
39
|
Adjuvant radiation therapy and chondroid chordoma subtype are associated with a lower tumor recurrence rate of cranial chordoma.
|
J Neurooncol
|
2009
|
0.80
|
|
40
|
A comprehensive analysis of hearing preservation after radiosurgery for vestibular schwannoma: clinical article.
|
J Neurosurg
|
2013
|
0.80
|
|
41
|
Hearing preservation after LINAC radiosurgery and LINAC radiotherapy for vestibular schwannoma.
|
J Clin Neurosci
|
2012
|
0.80
|
|
42
|
Genetic expression profiles of adult and pediatric ependymomas: molecular pathways, prognostic indicators, and therapeutic targets.
|
Clin Neurol Neurosurg
|
2013
|
0.79
|
|
43
|
Chromosomal alterations, prognostic factors, and targeted molecular therapies for malignant meningiomas.
|
J Clin Neurosci
|
2012
|
0.79
|
|
44
|
Comprehensive review of stereotactic radiosurgery for medically and surgically refractory pituitary adenomas.
|
Surg Neurol Int
|
2012
|
0.79
|
|
45
|
Monitoring immune responses after glioma vaccine immunotherapy.
|
Neurosurg Clin N Am
|
2010
|
0.79
|
|
46
|
Implications of cystic features in vestibular schwannomas of patients undergoing microsurgical resection.
|
Neurosurgery
|
2011
|
0.78
|
|
47
|
The tumor biology and molecular characteristics of medulloblastoma identifying prognostic factors associated with survival outcomes and prognosis.
|
J Clin Neurosci
|
2011
|
0.78
|
|
48
|
Emerging techniques in the minimally invasive treatment and management of thoracic spine tumors.
|
J Neurooncol
|
2011
|
0.78
|
|
49
|
An analysis of intracranial epidermoid tumors with malignant transformation: treatment and outcomes.
|
Clin Neurol Neurosurg
|
2012
|
0.78
|
|
50
|
Tumor control after surgery and radiotherapy for pineocytoma.
|
J Neurosurg
|
2010
|
0.77
|
|
51
|
A critical evaluation of vestibular schwannoma surgery for patients younger than 40 years of age.
|
Neurosurgery
|
2010
|
0.77
|
|
52
|
Molecular characteristics and pathways of Avastin for the treatment of glioblastoma multiforme.
|
Neurosurg Clin N Am
|
2012
|
0.76
|
|
53
|
Outcomes of stereotactic radiosurgery and stereotactic radiotherapy for the treatment of vestibular schwannoma.
|
Neurosurgery
|
2013
|
0.76
|
|
54
|
Biologic principles of immunotherapy for malignant gliomas.
|
Neurosurg Clin N Am
|
2010
|
0.76
|
|
55
|
Nanotechnology to augment immunotherapy for the treatment of glioblastoma multiforme.
|
J Neurooncol
|
2015
|
0.75
|
|
56
|
The value of intraoperative facial nerve electromyography in predicting facial nerve function after vestibular schwannoma surgery.
|
J Clin Neurosci
|
2010
|
0.75
|
|
57
|
Delayed intracranial and bony metastasis of paraganglioma.
|
Surg Neurol Int
|
2011
|
0.75
|
|
58
|
Neurosurgery concepts: Key perspectives on regulatory proteins, management of ossification of the posterior longitudinal ligament, and radiosurgery for intracranial lesions.
|
Surg Neurol Int
|
2013
|
0.75
|
|
59
|
Passive immunotherapeutic strategies for the treatment of malignant gliomas.
|
Neurosurg Clin N Am
|
2012
|
0.75
|
|
60
|
Perspectives on key articles in neurosurgery.
|
Surg Neurol Int
|
2012
|
0.75
|
|
61
|
Preface.
|
Neurosurg Clin N Am
|
2010
|
0.75
|
|
62
|
Akt/PKB Activation Facilitates Immune Escape in Glioma Patients 908.
|
Neurosurgery
|
2006
|
0.75
|
|
63
|
Non-audiofacial morbidity after Gamma Knife surgery for vestibular schwannoma.
|
J Neurosurg
|
2013
|
0.75
|
|
64
|
Occipital ganglioglioma in an older adult.
|
J Clin Neurosci
|
2010
|
0.75
|
|
65
|
Neuropathologic analysis of hematomas evacuated from patients with spontaneous intracerebral hemorrhage.
|
Neuropathology
|
2013
|
0.75
|
|
66
|
Endogenous vaults and bioengineered vault nanoparticles for treatment of glioblastomas: implications for future targeted therapies.
|
Neurosurg Clin N Am
|
2012
|
0.75
|
|
67
|
Surgical resection and adjuvant radiotherapy for a large pineal hemangiopericytoma.
|
J Clin Neurosci
|
2010
|
0.75
|
|
68
|
Pineal cyst: a review of clinical and radiological features.
|
Neurosurg Clin N Am
|
2011
|
0.75
|
|
69
|
Increasing social capital via local networks: analysis in the context of a surgical practice.
|
Am Surg
|
2002
|
0.75
|
|
70
|
Rib head disarticulation for multilevel transpedicular thoracic corpectomies and expandable cage reconstruction.
|
Neurol India
|
2009
|
0.75
|
|
71
|
Signal quality classification for an ambulatory monitoring system.
|
Conf Proc IEEE Eng Med Biol Soc
|
2010
|
0.75
|
|
72
|
Management of ovarian cysts in women undergoing restorative proctocolectomy for ulcerative colitis.
|
Am Surg
|
2003
|
0.75
|